INTERNATIONAL PATENT: BLISS BIOPHARMACEUTICAL (HANGZHOU) CO., LTD., 百力司康生物医药（杭州）有限公司 FILES APPLICATION FOR "PHARMACEUTICAL COMBINATION COMPRISING ANTIBODY-DRUG CONJUGATE AND IMMUNE CHECKPOINT INHIBITOR AND APPLICATION THEREOF"

GENEVA, March 16 -- BLISS BIOPHARMACEUTICAL (HANGZHOU) CO., LTD. (Building 7, Hexiang Technology Center, Qiantang AreaHangzhou, Zhejiang 310018), 百力司康生物医药（杭州）有限公司 (中国浙江省杭州市钱塘区和享科技中心7幢) filed a patent application (PCT/CN2025/119407) for "PHARMACEUTICAL COMBINATION COMPRISING ANTIBODY-DRUG CONJUGATE AND IMMUNE CHECKPOINT INHIBITOR, AND APPLICATION THEREOF" on Sep 05, 2025. With publication no. WO/2026/052074, the details related to the patent application was published on Mar 12, 2026.

Notably, the patent app...